A Chester-headquartered specialist infection prevention and control company has secured approval for a UK patent, following its discovery of unique anti-viral properties of certain enhanced extracts of commonly available brown seaweed.
The award for Byotrol is a result of years of research by its technical team at its laboratories at Thornton Science Park – a University of Chester campus.
It has also been supported by research scientists at the University of Liverpool, led by professor James Stewart, and by funding received from the Biotechnology and Biological Sciences Research Council (BBSRC) and Innovate UK.
The grant of the patent application gives Byotrol "validated, valuable and protected intellectual property" to support the development of commercial relationships.
In the UK and Europe, seaweed extracts are not as yet approved as active materials for biocidal products. As such, Byotrol is now actively exploring alternative applications in "very sizeable markets" such as over-the-counter products for the prophylactic treatment of viral conditions including colds, flu, coronaviruses and cold sores.
Read more at: Insider Media